Figure 4 | Scientific Reports

Figure 4

From: Multimodal Magnetic Resonance and Near-Infrared-Fluorescent Imaging of Intraperitoneal Ovarian Cancer Using a Dual-Mode-Dual-Gadolinium Liposomal Contrast Agent

Figure 4

Quantitative assessment of signal-to-noise ratio of DM-DualGd-ICG uptake in intraperitoneal (A) HeyA8 tumors and (B) OVCAR3 tumors and contrast-to-noise ratio of DM-DualGd-ICG uptake in intraperitoneal (C) HeyA8 tumors and (D) OVCAR3 tumors 48 hours after injection using MRI. *P < 0.05; n = 6 Hey-A8, n = 5 OVCAR3. Quantitative assessment of signal-to-noise ratio pre, immediate-post and 2 days after IV gadobenate dimeglumine in (E) HeyA8 tumors and (F) OVCAR3 tumors and contrast-to-noise ratio pre, immediate-post and 2 days after IV gadobenate dimeglumine in (G) HeyA8 tumors and (H) OVCAR3 tumors. *P < 0.05; n = 6 Hey-A8, n = 6 OVCAR3.

Back to article page